Drug and disease similarity calculation platform for drug repositioning

Drug repositioning, aiming to infer potential indications for drugs efficiently, has achieved remarkable results in reducing the cycle, cost and risk of drug Research and Development (R&D), and mining new uses of known drugs. Currently, many computational drug repositioning strategies have been proposed. The similarity calculation, as one of the key steps of drug repositioning, has an important impact on the accuracy of computational drug repositioning. However, the biological data used for the similarity calculation come from a wide range of sources with different formats, and similarity calculation methods are developed in different programming languages, thus the similarity calculation methods are varying. To facilitate the similarity calculation for drug repositioning, we developed a computational platform consisting of various datasets and similarity measures for drugs and diseases, and four programming languages (Java, R, Python and MATLAB) are supported by our platform. Users can use relevant data and methods directly according to their needs and customize similarity calculation methods. The platform is available at: http://bioinformatics.csu.edu.cn/artemis/.

[1]  A. Barabasi,et al.  Human symptoms–disease network , 2014, Nature Communications.

[2]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[3]  Philip Resnik,et al.  Using Information Content to Evaluate Semantic Similarity in a Taxonomy , 1995, IJCAI.

[4]  Yaohang Li,et al.  Computational drug repositioning using low-rank matrix approximation and randomized algorithms , 2018, Bioinform..

[5]  David W. Conrath,et al.  Semantic Similarity Based on Corpus Statistics and Lexical Taxonomy , 1997, ROCLING/IJCLCLP.

[6]  Philip E. Bourne,et al.  PROMISCUOUS: a database for network-based drug-repositioning , 2010, Nucleic Acids Res..

[7]  Jiajie Peng,et al.  SemFunSim: A New Method for Measuring Disease Similarity by Integrating Semantic and Gene Functional Association , 2014, PloS one.

[8]  Ying Fu,et al.  LRSSL: predict and interpret drug‐disease associations based on data integration using sparse subspace learning , 2017, Bioinform..

[9]  A. Mollica,et al.  Recent application of analytical methods to phase I and phase II drugs development: a review. , 2011, Biomedical chromatography : BMC.

[10]  Min-Seok Kwon,et al.  IDMap: facilitating the detection of potential leads with therapeutic targets , 2008, Bioinform..

[11]  H. Paik,et al.  Unraveling human protein interaction networks underlying co-occurrences of diseases and pathological conditions , 2014, Journal of Translational Medicine.

[12]  H. Grabowski,et al.  Are the economics of pharmaceutical research and development changing? , 2012, PharmacoEconomics.

[13]  Yi Pan,et al.  Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm , 2016, Bioinform..

[14]  Qing-Yu He,et al.  DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis , 2015, Bioinform..

[15]  Natasa Przulj,et al.  Predicting disease associations via biological network analysis , 2014, BMC Bioinformatics.

[16]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[17]  Deendayal Dinakarpandian,et al.  Automated Ontological Gene Annotation for Computing Disease Similarity , 2010, Summit on translational bioinformatics.

[18]  Deendayal Dinakarpandian,et al.  Finding disease similarity based on implicit semantic similarity , 2012, J. Biomed. Informatics.

[19]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[20]  Egon L. Willighagen,et al.  The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..

[21]  Yibo Wu,et al.  GOSemSim: an R package for measuring semantic similarity among GO terms and gene products , 2010, Bioinform..

[22]  Xiang Zhang,et al.  Drug repositioning by integrating target information through a heterogeneous network model , 2014, Bioinform..

[23]  G. Vriend,et al.  A text-mining analysis of the human phenome , 2006, European Journal of Human Genetics.

[24]  Thomas Lengauer,et al.  A new measure for functional similarity of gene products based on Gene Ontology , 2006, BMC Bioinformatics.

[25]  Hui Liu,et al.  Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks , 2016, BMC Bioinformatics.

[26]  D. Dinakarpandian,et al.  A New Metric to Measure Gene Product Similarity , 2007, 2007 IEEE International Conference on Bioinformatics and Biomedicine (BIBM 2007).

[27]  Zhiyong Lu,et al.  A survey of current trends in computational drug repositioning , 2016, Briefings Bioinform..

[28]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[29]  Dekang Lin,et al.  An Information-Theoretic Definition of Similarity , 1998, ICML.

[30]  Marvin Johnson,et al.  Concepts and applications of molecular similarity , 1990 .

[31]  Amanda L. Garner,et al.  Repositioning of an existing drug for the neglected tropical disease Onchocerciasis , 2010, Proceedings of the National Academy of Sciences.

[32]  R. Tagliaferri,et al.  Discovery of drug mode of action and drug repositioning from transcriptional responses , 2010, Proceedings of the National Academy of Sciences.

[33]  R. Sharan,et al.  PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.

[34]  Ping Zhang,et al.  Towards Drug Repositioning: A Unified Computational Framework for Integrating Multiple Aspects of Drug Similarity and Disease Similarity , 2014, AMIA.

[35]  Philip S. Yu,et al.  A new method to measure the semantic similarity of GO terms , 2007, Bioinform..

[36]  Philip Resnik,et al.  Semantic Similarity in a Taxonomy: An Information-Based Measure and its Application to Problems of Ambiguity in Natural Language , 1999, J. Artif. Intell. Res..

[37]  Hao Ye,et al.  Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning , 2014, PloS one.

[38]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.